{"id":31904,"date":"2014-09-24T07:35:34","date_gmt":"2014-09-24T11:35:34","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31904"},"modified":"2014-09-24T07:35:34","modified_gmt":"2014-09-24T11:35:34","slug":"avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904","title":{"rendered":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/24\/2014 (wallstreetpr) \u2013 Pharmaceutical company, <strong>Avanir Pharmaceuticals Inc (NASDAQ:AVNR)<\/strong> said that it would be raising a little over $200 million from the issue of fresh shares to the general public. It would use the funds for general corporate purposes. The issue announcement comes on the heels of the company announcing favorable <a href=\"http:\/\/finance.yahoo.com\/news\/avanir-pharmaceuticals-announces-positive-phase-123000249.html\" target=\"_blank\">Phase II study<\/a> results of its AVP-923 for treating the agitation in patients.<\/p>\n<p style=\"text-align: justify;\"><strong>Public Offering<\/strong><\/p>\n<p style=\"text-align: justify;\">Avanir Pharmaceuticals Inc (NASDAQ:AVNR)\u00a0said that it would issue 18.2 million shares to the public, which was fully underwritten, its <a href=\"http:\/\/finance.yahoo.com\/news\/avanir-pharmaceuticals-announces-pricing-public-020000204.html\" target=\"_blank\">statement<\/a> revealed. The company has priced the share at $11.00 before any discounts of underwriting.<\/p>\n<p style=\"text-align: justify;\">Avanir Pharmaceuticals also indicated that it has given an option of 30-days to the underwriters to acquire an additional 2.73 million shares in connection with the public issue.\u00a0Avanir Pharmaceuticals Inc (NASDAQ:AVNR) indicated that it was selling shares and that there was no other stakeholder involved in selling of shares.<\/p>\n<p style=\"text-align: justify;\">The issue, which would be anticipated to close on or before September 29, would generate gross proceeds of $200.2 million. This excluded the options provided to the underwriters, and in case the underwriters chose to acquire them,\u00a0Avanir Pharmaceuticals Inc (NASDAQ:AVNR) would get an additional $30 million from the issue.<\/p>\n<p style=\"text-align: justify;\"><strong>Issue Managers<\/strong><\/p>\n<p style=\"text-align: justify;\">Avanir Pharmaceuticals Inc (NASDAQ:AVNR)\u00a0indicated that apart from using the funds for its general corporate purposes, it would also use the funds for commercial activities of NUEDEXTA, future clinical studies, and the commercial launch of AVP-825 on approval from the regulator. It would use the funds to partly payoff its debt besides investing or acquiring in complementary products or businesses.<\/p>\n<p style=\"text-align: justify;\">The joint book-running managers to the issue were Deutsche Bank Securities, J.P. Morgan and Bank of America Merrill Lynch while JMP Securities and Piper Jaffray acted as co-managers to the issue.<\/p>\n<p style=\"text-align: justify;\">Avanir Pharmaceuticals Inc (NASDAQ:AVNR)\u00a0said that shelf registration statement in connection with the issue of shares was filed with the regulator and became effective automatically on September 22. It said that the prospectus were filed with the Securities and Exchange Commission and can be accessed through its website.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/24\/2014 (wallstreetpr) \u2013 Pharmaceutical company, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) said that it would be raising a little over $200 million from the issue [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":31909,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,263],"tags":[2502,2503,8464],"stock_ticker":[],"class_list":["post-31904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-technology","tag-avanir-pharmaceuticals-inc-nasdaqavnr","tag-nasdaqavnr","tag-piper-jaffray","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/24\/2014 (wallstreetpr) \u2013 Pharmaceutical company, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) said that it would be raising a little over $200 million from the issue [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-24T11:35:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"59\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering\",\"datePublished\":\"2014-09-24T11:35:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg\",\"keywords\":[\"Avanir Pharmaceuticals Inc. (NASDAQ:AVNR)\",\"NASDAQ:AVNR\",\"Piper Jaffray\"],\"articleSection\":[\"Health\",\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\",\"name\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg\",\"datePublished\":\"2014-09-24T11:35:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg\",\"width\":320,\"height\":59},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904","og_locale":"en_US","og_type":"article","og_title":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR","og_description":"Boston, MA 09\/24\/2014 (wallstreetpr) \u2013 Pharmaceutical company, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) said that it would be raising a little over $200 million from the issue [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-24T11:35:34+00:00","og_image":[{"width":320,"height":59,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering","datePublished":"2014-09-24T11:35:34+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg","keywords":["Avanir Pharmaceuticals Inc. (NASDAQ:AVNR)","NASDAQ:AVNR","Piper Jaffray"],"articleSection":["Health","Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904","url":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904","name":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg","datePublished":"2014-09-24T11:35:34+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/09\/index30.jpg","width":320,"height":59},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-to-raise-200-million-from-public-share-offering-31904#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR) To Raise $200 Million From Public Share Offering"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31904"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/31909"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31904"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}